Medications

Combi-seq: A leap forward for personalized cancer therapy

Each year, around 10 million lives around the world are cut short by cancer. While the last century of research has seen the number of approved anticancer drugs grow by leaps and bounds, the sheer diversity of disease forms ...

Oncology & Cancer

Novel therapeutic strategy shows promise against pancreatic cancer

Pancreatic cancer is notoriously difficult to cure or even treat. Now, a new strategy devised by scientists at Albert Einstein College of Medicine has succeeded in making pancreatic tumors visible to the immune systems of ...

Oncology & Cancer

Novel therapeutic approaches for aggressive bone cancer

Osteosarcoma (OS) is the most common form of aggressive bone cancer. A MedUni Vienna study led by geneticist Erwin Wagner has uncovered new insights into the disease mechanisms of OS, paving the way for potential new diagnostic ...

Diseases, Conditions, Syndromes

Study finds way to disarm dangerous bacteria

In Australia, more than 10,000 patients a year acquire a serious bacterial infection called Clostridioides difficile, often while in hospital, resulting in the death of up to 300 people per year. The Centers for Disease Control ...

page 2 from 21